---
schema_version: "secwatch.filing_event.v1"
accession: "0001110803-25-000071"
form_type: "8-K"
ticker: "ILMN"
cik: "0001110803"
company_name: "ILLUMINA, INC."
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:14:12.271490+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Illumina Q3 revenue $1.08B flat YoY, non-GAAP EPS $1.34 beats; raises FY EPS guidance to $4.65-$4.75

## Summary
- Q3 GAAP diluted EPS $0.98, non-GAAP diluted EPS $1.34; non-GAAP operating margin 24.5%.
- Revenue $1.08B flat YoY on reported and constant currency; returned to growth ex-China.
- FY2025 guidance raised: revenue decline narrowed to (1.5%)-(0.5%), non-GAAP EPS to $4.65-$4.75 from $4.45-$4.55.
- Repurchased 1.2M shares for $120M at avg $97.10; cash flow from ops $284M, free cash flow $253M.
- Launched new products: 5-base solution, Constellation mapped read tech, BioInsight, and Illumina Protein Prep.

## SEC filing metadata
- accession: 0001110803-25-000071
- form_type: 8-K
- ticker: ILMN
- cik: 0001110803
- company_name: ILLUMINA, INC.
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1110803/000111080325000071/0001110803-25-000071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1110803/000111080325000071/ilmn-20251030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001110803-25-000071
- JSON: https://secwatch.observer/filing/0001110803-25-000071.json
- Plain text: https://secwatch.observer/filing/0001110803-25-000071.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.